Literature DB >> 4552918

Unexpected toxicity in patients treated with iphosphamide.

J J Van Dyk, H C Falkson, A M Van der Merwe, G Falkson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4552918

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  30 in total

1.  [Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].

Authors:  N Brock; J Stekar; J Pohl
Journal:  Naturwissenschaften       Date:  1979-01

2.  Ifosfamide induced Fanconi syndrome.

Authors:  Samantha Buttemer; Mohan Pai; Keith K Lau
Journal:  BMJ Case Rep       Date:  2011-12-20

Review 3.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

4.  Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.

Authors:  M P Goren; C B Pratt; M J Viar
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Hypophosphataemic rickets after ifosfamide treatment in children.

Authors:  R Skinner; A D Pearson; L Price; K Cunningham; A W Craft
Journal:  BMJ       Date:  1989-06-10

Review 6.  Renal toxicity and chemotherapy in children with cancer.

Authors:  Antonio Ruggiero; Pietro Ferrara; Giorgio Attinà; Daniela Rizzo; Riccardo Riccardi
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

7.  Ifosfamide plasma clearance in relation to polymorphic debrisoquine oxidation.

Authors:  P A Philip; L D Lewis; C A James; H J Rogers
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.

Authors:  R C Stuart-Harris; P G Harper; C A Parsons; S B Kaye; C A Mooney; N F Gowing; E Wiltshaw
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 9.  Dosing and side-effects of ifosfamide plus mesna.

Authors:  W P Brade; K Herdrich; U Kachel-Fischer; C E Araujo
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

10.  Ifosfamide chemotherapy for pancreatic carcinoma.

Authors:  L H Einhorn; P J Loehrer
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.